IO Biotech, Inc.
IOBT · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $230 | $234 | $227 | $219 |
| Gross Profit | -$230 | -$234 | -$227 | -$219 |
| % Margin | – | – | – | – |
| R&D Expenses | $13,742 | $16,652 | $16,375 | $21,147 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $5,383 | $6,284 | $5,982 | $5,577 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $19,125 | $22,936 | $22,357 | $26,724 |
| Operating Income | -$19,355 | -$23,170 | -$22,584 | -$26,943 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | $9,313 | -$2,929 | $309 | -$3,945 |
| Pre-Tax Income | -$10,042 | -$26,099 | -$22,275 | -$30,888 |
| Tax Expense | -$1,664 | $118 | $146 | $445 |
| Net Income | -$8,378 | -$26,217 | -$22,421 | -$31,333 |
| % Margin | – | – | – | – |
| EPS | -0.13 | -0.4 | -0.34 | -0.48 |
| % Growth | 67.5% | -17.6% | 29.2% | – |
| EPS Diluted | -0.13 | -0.4 | -0.34 | -0.48 |
| Weighted Avg Shares Out | 66,942 | 65,881 | 65,881 | 65,881 |
| Weighted Avg Shares Out Dil | 66,942 | 65,881 | 65,881 | 65,881 |
| Supplemental Information | – | – | – | – |
| Interest Income | $255 | $285 | $414 | $722 |
| Interest Expense | $886 | $253 | $0 | $0 |
| Depreciation & Amortization | $230 | $234 | $227 | $219 |
| EBITDA | -$8,926 | -$25,612 | -$22,048 | -$30,669 |
| % Margin | – | – | – | – |